Ontogeny of the human thymus during fetal development David F. LobachBarton F. Haynes Special Article Pages: 81 - 97
Phenotypical and functional analysis of B lymphocytes of two siblings with combined immunodeficiency and defective expression of major histocompatibility complex (MHC) class II antigens on mononuclear cells Ger T. RijkersJohn J. RoordBen J. M. Zegers Original Articles Pages: 98 - 106
Increased spontaneous immunoglobulin secretion associated with cyclophosphamide-induced immune suppression Otoniel Martínez-MazaDewey J. MoodyJohn L. Fahey Original Articles Pages: 107 - 113
Membrane IgD-positive B cells of “low-IgD serum phenotype” individuals fail to secrete IgD and fail to shift to preferential lambda light-chain expressionin vitro Stephen D. LitwinBradley D. Zehr Original Articles Pages: 114 - 120
Monocyte (macrophage)-specific antibodies in patients with systemic lupus erythematosus (SLE) Fumihiko ShirakawaUki YamashitaHidero Suzuki Original Articles Pages: 121 - 129
The significance of antilymphocyte antibodies in patients with acquired immune deficiency syndrome (AIDS) and their sexual partners Gungor E. OzturkPeter F. KohlerCharles H. Kirkpatrick Original Articles Pages: 130 - 139
Selective alterations in immunoregulatory lymphocyte subsets in early HIV (human T-lymphotropic virus type III/lymphadenopathy-associated virus) infection Janis V. GiorgiParunag G. NishanianRoger Detels Original Articles Pages: 140 - 150
Human bone marrow-derived IgA is produced by IgA-committed B cellsin vitro Charles D. Alley Original Articles Pages: 151 - 158
Sensitization to epithelial antigens in chronic mucosal inflammatory disease. III. Serum factor modulates circulating and mucosal mononuclear-cell reactivity to epithelial cell-associated components of colon (ECAC-C) Gail DunkelJoseph W. PaulJames K. Roche Original Articles Pages: 159 - 173
Lymphocyte responses to varicella zoster virus in the elderly Anthony R. HaywardMark Herberger Original Articles Pages: 174 - 178
Preferential human eosinophil chemotactic activity of the platelet-activating factor (PAF) 1-0-hexadecyl-2-acetyl-sn-glyceryl-3-phosphocholine (AGEPC) C. Elliott SigalFrank H. ValoneEdward J. Goetzl Short Communication Pages: 179 - 184